An interventional study of MFR and Cognitive Behavior Therapy in Tension Type Headache, Myofascial Release Technique and Cognitive Behavior Therapy, sponsored by Dow University of Health Sciences. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by Dow University of Health Sciences · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of the study was to determine the effectiveness of myofascial release and cognitive behavior therapy in reducing stress, anxiety, depression, and neck disability in tension-type headache. The aim is to answer:
- Does the combination of myofascial release and cognitive behavior therapy reduce stress, anxiety, depression, and neck disability in TTH patients?
Participants were:
Background:
TTH is a mild-to-moderate intensity pain that feels like a tight band around the forehead, occiput, neck, and behind the eyes, with bilateral localization, and is not aggravated by any physical activity or related to nausea or vomiting. In addition, TTH patients may have discomfort when exposed to light or noise, but not simultaneously. According to the International Classification of Headache Disorders (ICHD) of 2018, TTH is divided into three types based on the frequency of episodes: infrequent episodic TTH (\< 1 day/month on average), frequent episodic TTH (1- 14 days/month on average), and chronic TTH (>15days/month on average).
The global prevalence of tension-type headaches is approximately 26.0% (22.7 - 29.5%). Globally, TTH incidence showed an overall upward trend from 1990 to 2019(4). An observed 1-year prevalence of TTH in Pakistan is around 44.7%. This is significantly higher than the global prevalence of TTH (5, 6). TTH in Pakistan appears to be more common among younger and middle-aged adults, with the highest prevalence reported in the 20-49 years age group. The prevalence tends to decrease in older age groups, but remains significant. Males are more prone to have TTH as compared to females, with a ratio of 4:3.
Myofascial release therapy will target the peripheral pain origin. MFR releases tension or restriction in the muscles by restoring their optimal length, decreasing pain, and improving function. It is a hands-on technique that treats pain as well as emotional bracing and holding patterns. Cognitive behavior therapy (CBT) focuses on behavior, cognition, and emotions. In the context of cognition, CBT helps individuals recognize negative thoughts that cause depression and anxiety. Then it assists in modifying negative thoughts and maladaptive thinking patterns. CBT includes behavioral activation and problem-solving techniques, which encourage individuals to replace negative behavior with positive behaviors and maintain them, which helps reduce anxiety and depression.
Because TTH has a complex pathophysiology, it is necessary to address both central and peripheral pain mechanisms. It is still unknown how well multidisciplinary collaborations like myofascial release therapy (a physiotherapy technique) with cognitive behavioral therapy (a psychotherapy technique) are effective in reducing stress, anxiety, depression, neck disability, and episodes of TTH. Although previous studies have shown the potential benefits of MRF and CBT for neck pain and psychological disorders, their relative effectiveness in the context of TTH has not been fully examined. A well-designed RCT is necessary to evaluate the effect of these two therapies in lowering stress and neck disability in individuals suffering from tension-type headaches, as indicated by the gap in this research.
METHODOLOGY Sample Description
Inclusion Criteria
Exclusion Criteria
Research Design The current study was a double-blind randomized controlled trial. The experimental group received myofascial release therapy and cognitive behavioral therapy, while the control group received MFR with placebo psychotherapy. The control group received talking control therapy. These were client-led sessions, did not challenge the patient's emotions, and had no core elements of CBT. This placebo psychotherapy was used to blind the participants to the nature of therapy. The assessor, who assessed the patients at the end of 4 weeks intervention and after 3 months follow up were blinded from the nature of treatment.
Data Collection Data collection started after approval from the IRB of Dow University of Health Sciences. The subjects were taken from the outpatient physiotherapy department referred by the neurologist. Before enrolling, the patient was screened and met the eligibility criteria. Patients between age 18 to 45year was taken. The purpose, objective of the study, information, risks, and possible benefits were explained to the patients by the therapist through an informed consent sheet. Each selected subject underwent random allocation to one of the two treatment groups with different interventions, i.e., experimental and control group, with the help of a computer-generated randomization sheet. Group A received MFR (Myofascial Release Therapy) + isometrics of neck muscles (physical therapy intervention) and CBT (Cognitive Behavioral Therapy). In contrast, group B (the control group) received MFR (Myofascial Release Therapy) + isometrics of neck muscles + placebo psychotherapy (talking control group). A hot pack was applied to both groups. Assessment was done at baseline and was re-evaluated after the completion of the 8th session by a therapist other than the principal investigator, who was blind to the patients' type of treatment. The follow-up of the patients was done after 3 months of treatment. The participants followed the home exercise plan for three months with same intensity and duration. The outcome measures were NPRS to measure headache intensity, the daily headache diary to monitor headache frequency and duration, NDI to assess neck disability, and DASS-21 to assess anxiety, depression, and stress. A total of 8 sessions of each therapy (MFR and CBT) were provided, each lasting 45 minutes. The professional clinical psychologist at the DIPM\&R OPD setting provided two sessions per week, with 45 minutes per session.
Setting Physiotherapy OPD at DIPMR, Ojha Hospital, Karachi, Pakistan.
Sample Size Open Epi online software was used to calculate the sample size. An independent sample t-test using the mean and SD of the Neck Disability Index at 4 weeks was 11.366±3.952 in Group MRT and CBT, and 9.322±4.407 in Group MRT alone(48), 95% confidence level and 80% power of the test. The sample size was 54 (27 cases and 27 controls) using the Fleiss method with continuity correction. After including a 15% dropout rate, a total of 54 patients were recruited and divided into 27 patients in each group (MFR+CBT = 27, MFR = 27)
Sampling Technique Non-probability purposive sampling technique.
Outcome Measures The outcome measures will be assessed at baseline and post-intervention, i.e., after 8 sessions.
Primary Outcomes:
Secondary Outcomes:
144 studies on the registry are indexed under Tension-Type Headache; 42 are open to participants now.
This study's enrollment of 54 is close to the median of 60 across 108 interventional studies indexed under Tension-Type Headache.
Browse Tension-Type Headache studies →Dow University of Health Sciences is the lead sponsor of 179 studies on the registry; 34 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Experimental Group: MFR + CBT + Neck Isometrics
Other: MFR · Behavioral: Cognitive Behavior Therapy
Control Group: MFR + Talking control(placebo psychotherapy) + Neck Isometrics
Other: MFR · Other: Talking Control (Placebo Psychotherapy)
MFR: Myofascial release therapy will target the peripheral pain origin. MFR releases tension or restriction in the muscles by restoring their optimal length, decreasing pain, and improving function. It is a hands-on technique that treats pain as well as emotional bracing and holding patterns. Some speculate that restriction in one part of the body produces tension in other parts due to its continuity.
CBT: CBT includes behavioral activation and problem-solving techniques, which encourage individuals to replace negative behaviors with positive behaviors and maintain positive behaviors, which help reduce anxiety and depression.
Talking Control(Placebo Psychotherapy): In this study, placebo psychotherapy was used to blind the patients in a control group. Talking control does not include any specific CBT elements. Talking control (TC) consists of client-led sessions and covers topics that challenge patients' beliefs or emotions. It includes health, religion, and TV programs.
Depression, Anxiety, Stress Scale (DASS- 21)
DASS-21 is commonly used to assess depression, anxiety, and stress. It consists of three subscales: depression, anxiety, and stress
Time frame: 4 weeks
Neck Disability Index (NDI)
The NDI assesses how neck pain affects individuals' everyday lives and comprises 10 items. It evaluates neck pain and the functional status of a person with neck pain.
Time frame: 4 weeks
Numeric Pain Rating Scale
A numeric pain rating scale is used for pain assessment. It is an 11-point scale scored from 0-10(32); "1-3" = mild pain, "4-6" = moderate pain, "7-10" = severe pain.
Time frame: 4 weeks
Headache Intensity & Frequency
The headache frequency and intensity have been measured using a headache diary. The patient has provided the diary, which they updated daily and in which they recorded the reduction or increase in headache pain, intensity, and frequency.
Time frame: 4 weeks
Plan to share: No — While signing the consent form with patients, it was decided that we would not share the patient data with anyone. It will remain private between the patient and the researcher.
No publications or documents are linked to this record.
Ran from Jun 2025 to primary completion in Mar 2026, 9 months.
Of 49 non-industry interventional studies with no phase under Tension-Type Headache, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 32. This study's 9 months is above that.
Counting every sponsor, half of 49 studies reached it within 7 months; a quarter within 3 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dow University of Health Sciences →